InsidersTradesSigma
Track the Mendus AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Mendus AB has logged 24 insider filings. The latest transaction was reported on 27 July 2026 (Purchase). Among the most active insiders: Helen Tuvesson Andersson. Every trade is accessible without an account.
24
Insider Decl.
n/a
Thresholds
€421,777
24 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 July 2026
Declarations24 total
10,240 shares@ SEK 6.50AktieISIN SE0022239950FI:csv-899d0cd7ad4aa78b2d81
20,641 shares@ SEK 6.5032.9% of flowAktieISIN SE0022239950FI:csv-52e72f7a406f646a662c
9,185 shares@ SEK 6.5048.6% of flowAktieISIN SE0022239950FI:csv-fd5ceac8866931e449c3
10,673 shares@ SEK 6.5014.1% of flowAktieISIN SE0020541563FI:csv-932500db13ca6f670d8d
9,300 shares@ SEK 6.5013.7% of flowAktieISIN SE0025196835FI:csv-c144964152e1eac133f8
174,804 shares@ SEK 5.6249.4% of flowAktieISIN SE0005003654FI:csv-5134051754c084a32402
60,228 shares@ SEK 5.6293.3% of flowAktieISIN SE0005003654FI:csv-04fabc5bb906440ca2f2
2,500 shares@ SEK 5.1052.6% of flowAktieISIN SE0005003654FI:csv-43f0d78f55d8afcb70c2
2,272 shares@ SEK 5.1047.4% of flowAktieISIN SE0005003654FI:csv-5cb62e7194beec084a3b
72,388 shares@ SEK 5.1550.0% of flowAktieISIN SE0005003654FI:csv-a56bee36a0b21c1479d7
72,388 shares@ SEK 5.168100.0% of flowAktieISIN SE0005003654FI:A003Y557-1
15,654 shares@ €0.391225.2% of flowAktieISIN SE0020541563FI:A003X591-1
16,315 shares@ €0.391216.8% of flowAktieISIN SE0020541563FI:A003X579-1
32,189 shares@ €0.39151.3% of flowAktieISIN SE0020541563FI:A003X583-1
12,993 shares@ €0.473725.3% of flowAktieISIN SE0022239950FI:A003V088-1
55,000 shares@ €0.457866.4% of flowAktieISIN SE0022239950FI:A003U944-2
200,000 shares@ €0.4578100.0% of flowAktieISIN SE0022239950FI:A003U933-1
10,237 shares@ €0.621716.8% of flowAktieISIN SE0020541563FI:A003T196-1
9,822 shares@ €0.621725.1% of flowAktieISIN SE0022239950FI:A003T160-1
9,130 shares@ €0.6217100.0% of flowAktieISIN SE0022239950FI:A003T076-1
17,842 shares@ €0.670548.7% of flowAktieISIN SE0022239950FI:A003Q912-1
8,797 shares@ €0.675824.4% of flowAktieISIN SE0022239950FI:A003Q888-1
13,861 shares@ €0.4832100.0% of flowAktieISIN SE0022239950FI:A003P643-1
7,780 shares@ €0.65230.0015% mcap100.0% of flowAktieISIN SE0005003654FI:A003M534-1
24 of 24 declarations
About Mendus AB
Mendus AB is a biopharmaceutical company focused on developing immunological treatments for cancer. It is listed on the Stockholm Stock Exchange.
